IGF2BP2 has also been reported to be related to patient outcomes in individuals with colorectal cancer27, hepatocellular carcinoma28, pancreatic cancer29, gastric cancer30, and OSCC31, while LPPPRC is an independent predictor of prognostic outcomes in many cancers. The gene discussed is IGF2BP2; the disease is cancer.